542918 Stock Overview Provides diagnostic and related healthcare tests and services in India. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Gian Life Care Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Gian Life Care Historical stock prices Current Share Price ₹18.76 52 Week High ₹29.00 52 Week Low ₹17.01 Beta 0.37 1 Month Change -7.27% 3 Month Change -13.95% 1 Year Change -4.33% 3 Year Change -51.36% 5 Year Change n/a Change since IPO 87.60%
Recent News & Updates
Gian Life Care Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 09
Investor sentiment improves as stock rises 16% Nov 04
Gian Life Care Limited, Annual General Meeting, Sep 30, 2024 Sep 10
New major risk - Share price stability Aug 16
First quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.25 in 1Q 2024) Aug 15
Gian Life Care Limited to Report Q1, 2025 Results on Aug 14, 2024 Aug 09 See more updates
Gian Life Care Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 09
Investor sentiment improves as stock rises 16% Nov 04
Gian Life Care Limited, Annual General Meeting, Sep 30, 2024 Sep 10
New major risk - Share price stability Aug 16
First quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.25 in 1Q 2024) Aug 15
Gian Life Care Limited to Report Q1, 2025 Results on Aug 14, 2024 Aug 09
Full year 2024 earnings released: EPS: ₹4.02 (vs ₹1.03 in FY 2023) Jun 04
New minor risk - Share price stability May 30
Investor sentiment improves as stock rises 22% May 30
Gian Life Care Limited to Report Q4, 2024 Results on May 30, 2024 May 24
Investor sentiment improves as stock rises 18% Feb 22
Investor sentiment improves as stock rises 15% Jan 21
Third quarter 2024 earnings released: EPS: ₹1.50 (vs ₹0.46 in 3Q 2023) Jan 14
Gian Life Care Limited to Report Q3, 2024 Results on Jan 13, 2024 Jan 08
Gian Life Care Limited to Report Q2, 2024 Results on Nov 11, 2023 Nov 07
Gian Life Care Limited, Annual General Meeting, Sep 30, 2023 Sep 09
First quarter 2024 earnings released: EPS: ₹0.25 (vs ₹0.08 loss in 1Q 2023) Aug 13
Gian Life Care Limited to Report Q1, 2024 Results on Aug 11, 2023 Aug 04
Full year 2023 earnings released: EPS: ₹1.03 (vs ₹4.23 in FY 2022) Jun 04
Gian Life Care Limited to Report Q4, 2023 Results on May 30, 2023 May 25
Investor sentiment improves as stock rises 29% Apr 12
Investor sentiment deteriorates as stock falls 18% Mar 29
Investor sentiment improved over the past week Jan 10
Investor sentiment deteriorated over the past week Nov 21
Gian Life Care Limited to Report First Half, 2023 Results on Nov 14, 2022 Nov 08
Investor sentiment improved over the past week Nov 07
Investor sentiment deteriorated over the past week Oct 12
Full year 2022 earnings released: EPS: ₹4.23 (vs ₹1.95 in FY 2021) Sep 18 Gian Life Care Limited, Annual General Meeting, Sep 30, 2022 Sep 15
Gian Life Care Limited Announces Board Appointments Sep 07
Investor sentiment deteriorated over the past week Sep 07
Investor sentiment improved over the past week Jul 20
Investor sentiment improved over the past week Jun 24
Full year 2022 earnings released: EPS: ₹4.23 (vs ₹1.95 in FY 2021) Jun 01
Gian Life Care Limited to Report Q4, 2022 Results on May 30, 2022 May 25
Investor sentiment deteriorated over the past week May 18
Gian Life Care Limited Announces Resignation of Sanjay Bhargava as Chief Executive Officer May 08
Investor sentiment deteriorated over the past week Apr 18
Investor sentiment deteriorated over the past week Mar 10
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Mar 03
Gian Life Care Limited to Report Q3, 2022 Results on Mar 02, 2022 Feb 24
Investor sentiment deteriorated over the past week Feb 22
Investor sentiment improved over the past week Feb 07
High number of new directors Dec 31
Investor sentiment deteriorated over the past week Dec 15
Investor sentiment improved over the past week Nov 18
Investor sentiment deteriorated over the past week Nov 01
Investor sentiment improved over the past week Oct 08
Investor sentiment improved over the past week Sep 13
Investor sentiment improved over the past week Aug 11
Investor sentiment deteriorated over the past week Jul 27
Full year 2021 earnings released: EPS ₹4.29 (vs ₹3.13 in FY 2020) Jul 09
Investor sentiment improved over the past week Jun 29
Investor sentiment improved over the past week May 21
Investor sentiment improved over the past week May 04
Investor sentiment improved over the past week Apr 13
Investor sentiment deteriorated over the past week Mar 26
New 90-day low: ₹19.55 Mar 05
Investor sentiment deteriorated over the past week Mar 05
Gian Life Care Limited, Annual General Meeting, Mar 16, 2021 Mar 04 Shareholder Returns 542918 IN Healthcare IN Market 7D -1.2% -0.7% 0.2% 1Y -4.3% 37.3% 17.2%
See full shareholder returns
Return vs Market: 542918 underperformed the Indian Market which returned 17.2% over the past year.
Price Volatility Is 542918's price volatile compared to industry and market? 542918 volatility 542918 Average Weekly Movement 7.5% Healthcare Industry Average Movement 5.3% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 542918 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 542918's weekly volatility (7%) has been stable over the past year.
About the Company Gian Life Care Limited provides diagnostic and related healthcare tests and services in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also offers various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers.
Show more Gian Life Care Limited Fundamentals Summary How do Gian Life Care's earnings and revenue compare to its market cap? 542918 fundamental statistics Market cap ₹194.01m Earnings (TTM ) ₹38.96m Revenue (TTM ) ₹123.23m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 542918 income statement (TTM ) Revenue ₹123.23m Cost of Revenue ₹14.84m Gross Profit ₹108.39m Other Expenses ₹69.43m Earnings ₹38.96m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 3.77 Gross Margin 87.95% Net Profit Margin 31.62% Debt/Equity Ratio 24.2%
How did 542918 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/30 23:04 End of Day Share Price 2024/12/30 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Gian Life Care Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
